These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17848419)

  • 21. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
    Stanley M
    Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversy undermines support for state mandates on the human papillomavirus vaccine.
    Gollust SE; Dempsey AF; Lantz PM; Ubel PA; Fowler EF
    Health Aff (Millwood); 2010 Nov; 29(11):2041-6. PubMed ID: 21041746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hear all about it: nightly television news coverage of cervical cancer vaccination in the United States.
    Wallace LS; Ache KA
    J Low Genit Tract Dis; 2009 Jul; 13(3):154-8. PubMed ID: 19550212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New quadrivalent HPV vaccine developments.
    Tovar JM; Bazaldua OV
    Postgrad Med; 2008 Nov; 120(4):14-6. PubMed ID: 19020361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proposed HPV vaccine mandates rile health experts across the country.
    Savage L
    J Natl Cancer Inst; 2007 May; 99(9):665-6. PubMed ID: 17470731
    [No Abstract]   [Full Text] [Related]  

  • 28. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
    Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
    Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quadrivalent HPV vaccination reactions--more hype than harm.
    Douglas RJ
    Aust Fam Physician; 2009 Mar; 38(3):139-42. PubMed ID: 19283255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV vaccine mandates: just say 'no' to the "great big public health experiment".
    Onder RF
    Mo Med; 2008; 105(1):8-11. PubMed ID: 18300597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus vaccination: the policy debate over the prevention of cervical cancer--a commentary.
    Hoops KE; Twiggs LB
    J Low Genit Tract Dis; 2008 Jul; 12(3):181-4. PubMed ID: 18596458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adolescents' access and consent to the human papillomavirus vaccine: a critical aspect for immunization success.
    Farrell RM; Rome ES
    Pediatrics; 2007 Aug; 120(2):434-7. PubMed ID: 17671069
    [No Abstract]   [Full Text] [Related]  

  • 40. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.